News from the web:
University Feinberg School of Medicine have developed a new “one-size-fits-all” therapy drug that could potentially treat Alzheimer’s, Parkinson’s disease, multiple sclerosis and traumatic brain injury
The drug’s trick lies in reducing a particular type of inflammation in the brain known as neuroinflammation. This brain response has become increasingly considered a common denominator for many neurological disorders, as well as playing a major role in brain injuries. To decrease inflammation, the drug developed at Northwestern binds to and decreases a molecule known as cytokine, which is released in large quantities during the neuroinflammatory response.
Read all about it HERE
visit us at AlzheimerHeadlines.com